Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancer by Raj Hanvesakul, Badri Rengarajan, Navit Naveh, Anne Boccuti, Julie E Park, Adekemi Adeyemi, Clyde Caisip, Jeroen P Jansen, Florence R Wilson

Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis by Javier Cortes, Amin Haiderali, Min Huang, Wilbur Pan, Peter Schmid, Katherine G. Akers, Julie E. Park, Andrew M. Frederickson, Peter A. Fasching, Joyce O’Shaughnessy

Get full text